866181-59-1

Basic information

• Product Name: 3-Furancarbonitrile, 2-amino-4,5-bis(4-chlorophenyl)-
• CAS NO: 866181-59-1
• Molecular Formula: C17H10Cl2N2O
• Molecular Weight: 329.185
• Mol File: 866181-59-1.mol

Chemical Properties

• CAS DataBase Reference: 3-Furancarbonitrile, 2-amino-4,5-bis(4-chlorophenyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Furancarbonitrile, 2-amino-4,5-bis(4-chlorophenyl)-(866181-59-1)
• EPA Substance Registry System: 3-Furancarbonitrile, 2-amino-4,5-bis(4-chlorophenyl)-(866181-59-1)

Safety Data

• Hazardous Substances Data: 866181-59-1(Hazardous Substances Data)

Upstream product

• 104-88-1 4-chlorobenzaldehyde 
• 1867-38-5 4-chlorobenzylidenemalonodinitrile 
• 4254-20-0 4,4'-dichlorobenzoin 
• 109-77-3 malononitrile 

Relevant articles and documents

A NHC-Involved, cascade, metal-free, and three-component synthesis of 2,3-diarylated fully substituted furans under solvent-free conditions

An efficient synthesis of 2,3-diarylated fully substituted furans was performed through the sequential reactions of Knoevenagel reaction, Stetter reaction catalyzed by NHC, and intramolecular cyclization under solvent-free conditions. The protocol has the

An Efficient synthesis of 2-aminofuran-3-carbonitriles via cascade Stetter-γ-ketonitrile cyclization reaction catalyzed by N-heterocyclic carbene

An efficient method for the synthesis of 4,5-disubstituted 2-aminofuran-3-carbonitriles via a cascade Stetter-γ-ketonitrile cyclization reaction of aromatic aldehydes with acylidenemalononitriles, catalyzed by N-heterocyclic carbenes, has been developed.

COMPOUND FOR INHIBITING TYROSINE KINASE ACTIVITY OF DDR2 PROTEIN

A new furopyrimidine compound, their pharmaceutically acceptable salt, and a tyrosine kinase activity inhibitor. The furopyrimidine compound is a compound defined by chemical formula 1, 2, 3 or 4, on their precursor, and can exist as a form of free base or in an acid-addition salt. Since the furopyrimidine compound has an effect of inhibiting activity of DDR2 tyrosine kinase, it can be used in treating illnesses caused by the DDR2 tyrosine kinase activity such as hepatocirrhosis, rheumatoid arthritis or cancer.